KPMG – Healthcare and Life Sciences Investment Outlook 2026

This report provides insights based on extensive global research into deal and market environments in healthcare and life sciences.

It covers challenges faced in 2025 including uncertainty in deal markets, interest rate changes by the US Federal Reserve, government policy shifts, and pressures to reduce drug prices and reshore manufacturing. The report also highlights trends in mergers and acquisitions, particularly in healthcare services and healthcare information technology, and emphasizes the growing importance of digital tools to manage costs and improve efficiency.